Agilent Technologies Opens Center for Biopharma Solutions in Hyderabad

The facility, serving as a hub of Biopharma, offers solutions across chromatography, mass spectrometry, cell analysis, and lab informatics.

US-Based Agilent Technologies, a global firm focusing on life sciences and diagnostics, has launched its new Biopharma Experience Center in Hyderabad.

The facility represents a significant investment in India’s expanding life sciences ecosystem and aligns with Agilent’s broader three-to-five-year growth strategy for the country.

The facility, serving as a hub of Biopharma, offers solutions across chromatography, mass spectrometry, cell analysis, and lab informatics.

Inaugurated by Telangana IT Minister D. Sridhar Babu and Agilent CEO Padraig McDonnell, the centre provides advanced labs, expert training, and regulatory-ready solutions to support effective drug development.

“Hyderabad has emerged as a complete healthcare and life sciences ecosystem, from drug discovery to high-quality patient care,” said Babu. “With top global pharma companies and over 230 USFDA-approved manufacturing units, Telangana is making a strong national and international impact.”

Hyderabad boasts one of the most mature and future-focused life sciences ecosystems in India, with deep industry expertise, strong R&D capabilities, and a conducive policy environment.

Without mentioning either the investment or hiring plans, Agilent said its capital investment in the facility is part of a broader three-to-five-year India growth strategy.

Leveraging the city’s strength in generics and growing focus on advanced therapies, the new centre brings advanced analytical and regulatory capabilities to drive local innovation and global impact.

Earlier this year, Agilent also launched its India Solution Center in Manesar. With this expansion, the company is deepening customer partnerships and positioning India as a strategic hub in its global innovation and growth roadmap.

“Agilent is already working closely with many of India’s leading biopharma companies,” McDonnell said. “With this center, we aim to strengthen those relationships and co-create solutions that address the evolving needs of both Indian and global markets.”

Stay tuned for more such updates on Digital Health News